SIRT1 and Alzheimer disease: Donepezil, an acetylcholinesterase inhibitor used in the treatment of AD, is shown to promote angiogenesis, decrease BMEC permeability, and upregulate tight junction proteins via SIRT1-dependent pathways [69].